Pan, Lu
Parini, Paolo
Tremmel, Roman
Loscalzo, Joseph
Lauschke, Volker M.
Maron, Bradley A.
Paci, Paola
Ernberg, Ingemar
Tan, Nguan Soon
Liao, Zehuan
Yin, Weiyao
Rengarajan, Sundararaman
Li, Xuexin http://orcid.org/0000-0001-5824-9720
,
Funding for this research was provided by:
Karolinska Institutet (C62623013, C24401073, C331612602)
Karolinska Institute
Article History
Received: 16 November 2022
Accepted: 12 April 2024
First Online: 19 April 2024
Declarations
:
: Not applicable.
: Not applicable.
: VML is CEO and shareholder of HepaPredict AB, co-founder, and shareholder of PersoMedix AB, and discloses consultancy work for Enginzyme AB. The other authors declare that they have no competing interests.